Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.7241 | 62 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.66386 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.74011 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.73098 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.82065 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.82883 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.88826 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.99528 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.66039 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.86468 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.66404 | 61 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.3535 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.70286 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.66741 | 62 |